Eaton Vance Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,550
Closed -$73K 2445
2021
Q4
$73K Sell
3,550
-374
-10% -$7.99K ﹤0.01% 1947
2021
Q3
$0 Sell
3,924
-152
-4% -$3.66K ﹤0.01% 2499
2021
Q2
$118K Buy
4,076
+3,769
+1,228% +$102K ﹤0.01% 1834
2021
Q1
$7K Buy
+307
New +$6.93K ﹤0.01% 2464

Other funds holding PAHC

Eaton Vance Management's PAHC Position: Q1 2022 in Review

Eaton Vance Management sold out of Phibro Animal Health (PAHC) in Q1 2022, closing a stake of 3,550 shares — an estimated $73K sold.

Eaton Vance Management first reported a position in PAHC in Q1 2021 and held it in 4 quarters. The position peaked at $118K in Q2 2021. 153 funds tracked by Wall St. Rank hold PAHC as of Q1 2022.

  • Eaton Vance Management reported no remaining Phibro Animal Health position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 3,550 Phibro Animal Health shares in Q1 2022, an estimated $73K.
  • Eaton Vance Management first reported a position in Phibro Animal Health in Q1 2021 and held it in 4 quarters.
  • Eaton Vance Management's Phibro Animal Health position peaked at $118K in Q2 2021.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.